Tyrosinemia type I treated by NTBC: how does AFP predict liver cancer?

C.J. Koelink; P.M. van Hasselt; AT van der Ploeg; M.M. van den Heuvel-Eibrink; F.A. Wijburg; C.M.A. Bijleveld; F.J. van Spronsen

Tyrosinemia type I treated by NTBC: how does AFP predict liver cancer?

Translated title of the contribution: Tyrosinemia type I treated by NTBC: how does AFP predict liver cancer?

C.J. Koelink
, P.M. van Hasselt
, AT van der Ploeg
, M.M. van den Heuvel-Eibrink
, F.A. Wijburg
, C.M.A. Bijleveld
, F.J. van Spronsen

Metabolic diseases

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Tyrosinemia type I treated by NTBC: how does AFP predict liver cancer?
Original language	Undefined/Unknown
Pages (from-to)	310-315
Number of pages	6
Journal	Molecular Genetics and Metabolism
Volume	89
Issue number	4
Publication status	Published - 2006

Cite this

@article{ba8bc79a1d6f4f278ab592eacb5c8465,

title = "Tyrosinemia type I treated by NTBC: how does AFP predict liver cancer?",

author = "C.J. Koelink and \{van Hasselt\}, P.M. and \{van der Ploeg\}, AT and \{van den Heuvel-Eibrink\}, M.M. and F.A. Wijburg and C.M.A. Bijleveld and \{van Spronsen\}, F.J.",

year = "2006",

language = "Undefined/Unknown",

volume = "89",

pages = "310--315",

journal = "Molecular Genetics and Metabolism",

issn = "1096-7192",